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Summary 
Previous studies have shown that immature mouse class I molecules transiently associate with 
a resident endoplasmic reticulum protein of 88 kD that has been proposed to act as a chaperone 
for class I assembly. Subsequently, this protein was demonstrated to be identical to calnexin and 
to associate with immature forms of the T cell receptor complex, immunoglobulin, and human 
class I HLA heavy chains. In this paper we define further the interaction of human dass I HLA 
heavy chains with chaperone proteins and find key differences with the complexes observed in 
the mouse system. First, calnexin and immunoglobulin binding protein (BiP) both associate with 
immature HLA class I heavy chains. The two chaperones are not found within the same molecular 
complex, suggesting that calnexin and BiP do not interact simultaneously with the same HLA 
class I heavy chain. Second, only free HLA class I heavy chains, and not 32-microglobulin (Bzm)- 
associated  heavy chains are found associated  with the chaperones. Indeed, addition of free 32m 
in vitro induces dissociation of chaperone-class I HLA heavy chain complexes. The kinetics for 
dissociation of the class I HLA heavy chain-chaperone complexes and for formation of the class 
I  HLA  heavy chain-32m  complex display  a  reciprocity that  suggests  the interactions  with 
chaperone and 32m are mutually exclusive. Mouse class I heavy chains expressed in human cells 
exhibit the mouse pattern of interaction with human chaperones and human 32m and not the 
human pattern, showing the difference in behavior is purely a function of the class I heavy chain 
sequence. 
F 
unctional MHC class I molecules consist of a polymorphic 
class  I  heavy  chain,  32-microglobulin  (32m) 1 and  a 
bound peptide (1, 2). Class I heavy chains and 32m are syn- 
thesized on membrane bound ribosomes and then translo- 
cated into the lumen of the endoplasmic reticulum (ER) (3). 
Peptides  derive from protein degradation in the cytoplasm 
and are transported into the ER (4-8) where the association 
of heavy chains,/32m,  and peptides occurs. All three com- 
ponents are required for efficient transport from the ER. to 
the plasma membrane. Cells deficient in either 32m or pep- 
tide supply have greatly reduced levels of class I MHC mole- 
cules at the cell surface (9-16). 
Degen et al. (17,  18) showed that immature mouse class 
I molecules associate  transiently with a protein of 88  kD, 
which they proposed acted as a chaperone. This protein was 
shown to be identical to calnexin (19, 20), a calcium binding 
protein of the ER (21).  Subsequently, calnexin was found 
1 Abbreviations used in this paper: 32m, B2-microglobulin; BiP, immuno- 
globulin binding protein; B-LCL, B lymphoblastoid  cell line; DSP, di- 
thiobis(succinimidyl-propionate);  EndoH, endoglycosidase  H; ER, endo- 
plasmic reticulum; TAP, transporter-associated  protein. 
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to associate with human class I heavy chain, and also with 
immature forms of the T cell receptor and immunoglobulin 
(22-24). 
Previous studies have revealed intriguing differences in the 
interactions of class I MHC heavy chains and f32m in hu- 
mans and mice (for reference see 25). HLA class I heavy chains 
bind B2m more strongly than do mouse class I heavy chains, 
and incubation of human ceils in the presence of bovine 32m 
does not lead to significant 32m exchange, as is the case for 
mouse cells (25).  In mouse cell lines that lack expression of 
32m, some fraction of class I heavy chains reach the cell sur- 
face (26,  27).  This is  also  true for cells of mice rendered 
02m-negative through "knock-out" of the 32m gene (28, 
29),  for which incubation with exogenous 32m and an ap- 
propriate binding peptide can reconstitute functional class 
I molecules at the cell surface (30).  In contrast, class I heavy 
chains of the human cell line Daudi, which is defective in 
both 32m alleles, are trapped in the ER and appear actively 
prevented from reaching the cell surface (12). 
Cell lines negative for the peptide transporter genes, TAP, 
have limited peptide supply resulting in class I molecules largely 
devoid of peptides. Such "empty" mouse class I molecules 
expressed in the human TAP-negative cell line T2 are trans- 
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lents  are retained intracellularly  (31).  Furthermore,  empty 
mouse class  I molecules, although efficiently transported to 
the cell surface, are unstable at physiological temperature but 
can be stabilized by reducing the temperature to 25~  (16). 
In contrast, empty human class I molecules form stable het- 
erodimers  with  B~m,  even at  elevated temperature  (32). 
Collectively, these findings provide circumstantial evidence 
for differences in the biogenesis of class I MHC  molecules 
in human and mouse cells. One potential source of the differ- 
ence is  in  the  interaction  of the class  I  heavy chain  with 
chaperones, including calnexin. The experiments we report 
here were undertaken to define further the interaction of HLA 
class I heavy chains with intracellular chaperones and to com- 
pare their interaction with human and mouse class I heavy 
chains. 
Materiah  and Methods 
Cells.  Cells lines were cultured in RPMI 1640 supplemented 
with 10% FCS, 2 mM t-glutamine, 1.4 mM sodium pyruvate, and 
100 U/ml penicillinAtreptomycin (Irvine Scientific, Santa Ana, CA). 
The CIR cell line, a derivative  of the B lymphoblastoid cell line 
(B-LCL) Hym2 (33) and reduced in class I expression (34),  was 
stably  transfected  with  the B'2705,  B*0702,  and  K b genomic 
DNA clones to generate B27CIR.,  B7C1R, and KbC1R (provided 
by Dr. J. Alexander and Dr. P. Cresswell,  Yale University,  New 
Haven,  CT). EL4, a mouse T cell lymphoma of H-2  b haplotype 
and MDAY.D2,  an H-2d-expressing anaplastic  tumor cell line of 
lymphoreticular origin, were gifts from Dr. D.B. Williams (Univer- 
sity of Toronto, Toronto, Canada).  Daudi is a Burkitt's lymphoma 
cell line defective  for ~/zm expression  (35,  36). 
Antibodies.  Antibodies with reactivity for different forms of 
human MHC class I molecules were used: W6/32 and ME1 (37) 
recognize human MHC class I molecules only when associated with 
/~2m; Q1/28 recognizes predominantly free MHC class I heavy 
chains and to a lesser extent assembled MHC class I molecules (ref- 
erence in 37); A1.4 (Olympus Co., Lake Success, NY) reacts with 
free and B2m-associated class I molecules  (38); monoclonal anti- 
bodies LA45 (39, 40) and HC10 (41) bind free class I heavy chains. 
Antibodies L368 (42) and BBM1 (reference 37) were used to detect 
human B2m. Reagents specific for mouse MHC class I proteins 
were the gift of Dr. D.  B. Williams (reference in 17): rabbit an- 
tipeptide 8 antiserum reacts with free and ~zm-associated  H-2K  b 
and K d proteins,  and monoclonal antibody 20-8-4s  reacts  with 
H-2K  b and  K a when  associated  with  B2m. AF8 (22),  a mouse 
monoclonal antibody reacting with human calnexin, was a gift from 
Dr. M. B. Brenner (Harvard Medical School, Boston, MA). The 
anti-grp78/BiP monoclonal antibody, which also precipitates  the 
grp94/ER99 protein, was purchased from StressGen (Victoria, BC., 
Canada).  Nonimmune rabbit antiserum and monoclonal antibody 
CVC7 (anti-bovine clathrin light chain, LCa; reference in 37) were 
used as negative controls. 
Biosynthetic Radiolabelin,~ Cell Lysis, and Cross-linking.  For pulse/ 
chase experiments, 5  x  106 cells were used for each time point. 
After starvation  in  1 ml of methionine/cysteine-free culture me- 
dium/10%  FCS for 30 min, cells were pulsed  for 10 rain by the 
addition of 100 #Ci of TranSLabel (ICN Biomedicals  Inc., Cosa 
Mesa, CA). Chase was initiated by the addition of 9 vol of culture 
medium containing I mM nonradioactive  methionine and cysteine. 
At various time points, samples were removed, cooled quickly on 
ice, washed twice with ice-cold PBS, pH 8.0, and kept on ice until 
lysis with or without cross-linking. Cell lysis and cross-linking were 
performed as described (17) with minor modifications:  the cross- 
linking reagent, dithiobis(succinimidyl-propionate) (DSP;  Pierce 
Chemical Co., Rockford, IL), was dissolved freshly in DMSO at 
a concentration of 10 mg/ml and 3 ~1 were added simultaneously 
with 500 #1 of lysis buffer (0.5% NP-40, 10 mM iodoacetamide, 
0.2 mM PMSF in PBS, pH 8.0).  Lysis was performed on ice for 
30 min.  Cross-linking was  stopped by adding glycine to a final 
concentration ofS0 mM. Lysates  were precleared with 5/xl of normal 
rabbit  serum and  250/zl  of a  10%  solution of Pansorbin  cells 
(Calbiochem-Novabiochem Corp., San Diego, CA) for 4 h at 4~ 
Long-term labeling (15-20 h) was performed in 24-well plates. 
6  x  106 cells were resuspended  at a cell concentration of 2  x  1@ 
cells/ml in  methionine/cysteine-free RPMI  1640/10%  FCS  and 
starved for 30 min before radiohbeling with 100 #Ci/ml TranSLabel. 
After radiolabeling,  cell lysis and cross-linking were performed as 
described. 
Isolation of MHC Class I Molecules.  All procedures were per- 
formed at 4~  precleared cell lysates were immunoprecipitated with 
5 #1 of either purified monodonal antibody or rabbit antiserum 
or ascites fluid and 50 #1 of a 10% suspension  of Pansorbin  cells. 
Isolated immunocomplexes  were washed first in 1 ml of 1st washing 
buffer NTS (0.5% NP-40,  10 mM Tris-HC1 [pH 7.4], 0.15 mM 
NaC1, 1 mM MgC12) supplemented with SDS (0.1%) and deoxy- 
cholic acid (0.5%) and then in 1 ml of 2nd washing buffer (NTS, 
diluted  1/10  in  dH20  and  supplemented  with  0.5  M  NaCl). 
Samples were analyzed by gel electrophoresis.  For cleavage of the 
cross-linker, samples were resuspended in SDS-PAGE sample buffer 
containing 100 mM dithiothreitol (DTT) and 0.2% 2-mercapto- 
ethanol and boiled for 10 min before SDS-PAGE analysis. 
Digestion with endoglycosidase H (EndoH; Boehringer Mann- 
helm Corp., Indianapolis,  IN) was performed while immunocom- 
plexes were still bound to Pansorbin cells. Samples were resuspended 
in 60/xl of EndoH digestion buffer (0.1 M sodium citrate [pH 5.5], 
0.075% SDS, 0.2% 2-mercaptoethanol) and split into two equal 
aliquots, one of which received 2 mU of EndoH. 2-mercaptoethanol 
was omitted from DSP-treated samples to preserve cross-linked com- 
plexes. Digestion was carried out at 30~  overnight and termi- 
nated by the addition of SDS-PAGE sample buffer with or without 
the reducing agent,  DTT. 
Analysis of Cross-linked Complexes.  Protein complexes isolated 
from long-term labeled cells were detected by SDS-PAGE under 
nonreducing conditions.  Protein bands were excised from dried gels 
and eluted twice in  100/~I of PBS/1% SDS, each time for 24 h 
at room temperature. Eluted proteins were precipitated with ace- 
tone and subjected to EndoH digestion under reducing conditions. 
Samples were boiled before reanalysis by reducing SDS-PAGE. 
One-dimensional Peptide Mapping Using V8 Endotn~teinase.  Pep- 
tide maps for the 84- and 94-kD proteins, calnexin, grp78/BiP, 
grp94/ER99, and class I heavy chains were created by in-gel diges- 
tion using 0.6 #g ofStaph?lococcus aureus V8 endoproteinase  (Boeh- 
ringer Mannhein Corp.).  Radiolabeled  84-  and 94-kD proteins 
were isolated from the 160-kD bands obtained from cell lysates of 
200  x  10  ~ B27C1R or B7C1R cells that had been radiolabeled 
for 20 h and cross-linked as described.  Radiolabeled calnexin, BiP, 
and grp94 were immunoprecipitated from biosynthetically labeled 
noncross-linked B27C1R or B7CIR cell lysates using monoclonal 
antibodies  AF8 and anti-grp78, respectively. Class I HLA-B'0702 
heavy chains migrate as two distinct species on 10% nonreducing 
SDS-PAGE and both bands were eluted for V8 digestion. Eluted 
proteins were precipitated with acetone and analyzed by Cleveland 
mapping as described  (43,  44). 
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labeled with TranSLabel for 1 h and washed twice in PBS. Pellets 
of 7  x  10  + cells were resuspended in 250 #1 of 0.5% NP-40 lysis 
buffer containing  0,  0.5,  5,  or  50  #g  of either  purified  152m 
(Calbiochem-Novabiochem Corp.)  or chicken lysozyme (Sigma 
Chemical Co., St. Louis, MO) as a negative control protein. After 
preclearing the lysates with Pansorbin cells, immunoprecipitation 
was  performed  using  antibody  W6/32  to  determine  whether 
HC/132m  heterodimer formation occurred under the conditions 
applied. Precipitated material was analyzed by one-dimensional lEE 
For cross-linking experiments, lysis in the presence  of exogenous 
protein was initiated in the absence of cross-linker.  After incuba- 
tion for 15 min on ice, cross-linking was performed by. the addi- 
tion of 250 #1 of NP-40 lysis buffer containing 3/~1 of DSP (10 
mg/ml in DMSO) (final concentration of 0.2 mM). Cross-linking 
and immunoisolation of the 160 kD species were performed as de- 
scribed. 
As an alternative to NP-40 lysis, exogenous proteins were "fed 
to cells" using sonication.  Washed cell pellets  were resuspended 
in 250/~1  of  PBS containing purified proteins and sonicated (Branson 
Sonifer 450;  VWR  Scientific  Instruments,  Philadelphia,  PA) in 
pulsed mode at a fixed repetition rate of one pulseA  and a pulse 
duration of 20% of each second.  After sonication, samples were 
kept on ice for 15 rain before cross-linking was performed by addi- 
tion of 250/~1 of 1% NP-40 lysis buffer containing 3/~1 of DSP 
(10 mg/ml) to give a final concentration of 0.5% NP-40 and 0.2 
mM DSP. Immunoprecipitation was performed as before. No ap- 
preciable  difference in the amount of HC/132m  or 160-kD com- 
plexes resulted from the two protocols. 
Results 
Detection of a  160-kD HLA  Class I  Heavy  Chain~Protein 
Complex.  Using  a  cleavable  cross-linking  reagent  (DSP) 
Degen and Williams  (17) showed that  transport  of murine 
class I (H-2) major histocompatibility complex molecules from 
ER to Golgi is controlled by calnexin. We performed similar 
experiments upon human class I HLA molecules. Cells were 
biosynthetically labeled and then detergent solubilized in the 
presence or  absence  of DSP.  Class  I  HLA  molecules were 
immunoprecipitated and analyzed on nonreducing SDS-PAGE. 
To ensure the validity of the comparison we repeated the ex- 
periments of Degen and Williams,  confirming the presence 
of a 145-kD species in DSP-treated cell extracts after precipi- 
tation  with  anti  H-2  antibodies  (Fig.  1 a). 
Analogous experiments using human C1R cells transfected 
with either HLA-B*0702 or HLA-B*2705 genes revealed a 
160-kD  species in DSP-treated cell extracts (Fig.  1  b)  that 
was not seen in immunoprecipitates made from untreated ex- 
tracts. The cross-linked species from human ceUs was of slower 
electrophoretic mobility than that from mouse cells. Com- 
parison of human EBV-transformed B cell lines and CIR cells 
transfected with class I HLA genes showed that the 160-kD 
species was more abundant in the CIR transfectants and for 
that  reason  our  studies  focused on  them. 
Comparison  of  the  immunoprecipitates  obtained  with 
monoclonal antibodies directed against different epitopes of 
class I  HLA molecules revealed that detectable amounts  of 
the cross-linked 160-kD species were precipitated only by an- 
tibodies reactive with free class I heavy chains (Q1/28, LA45, 
A1.4,  and HC10).  Antibodies reactive with the complex of 
B2m,  heavy chain,  and  peptide  (W6/32,  ME1,  L368,  and 
BBM1) (Fig. 1 b) gave bands corresponding to the heavy chains 
(45 kD) and a cross-linked complex of heavy chains and ~32m 
(55 kD), but no 160-kD species was detected even after long 
Figure  1.  Detection  of a  160-kD 
HLA class I heavy chain/protein com- 
plex. 10% nonreducing SDS-PAGE  of 
class I immunoprecipitates  from radio- 
labeled (15 min) mouse (MDAY.D2 [a] 
and human (B7C1R [b])  cell lines. Ab- 
sence (-) or presence  (+) of  DSP is in- 
dicated. Antibody used in (a) is 20-8-4s 
recognizing flee  and  ~2m-associated 
H-2  K  b.  Antibodies used in (b) are: 
those specific for human flee class I 
heavy chains (Q1/28:  lanes I  and 5, 
LA45: lane 3; A1.4: lane 4); antibodies 
specific for human heavy chain/B2m 
complexes (HLA-HC/B2m) (W6/32: 
lane 8 and ME1: lane 9); those recog- 
nizing  human  ~zm  (BBMI: lane 6; 
and L368: lane 7); anti-bovine clathrin 
light chain, CVC7 (lane 10) and nonim- 
mune serum (lanes 2 and 11). Arrows 
indicate mouse H-2  class I/calnexin 
complex  (mccrmJ  to as 145 kD according 
to  reference 17), human HLA  class 
I/protein complex (apparent molecuhr 
mass of 160 kD),  mouse (H-2 HC/ 
~2m)  and  human  (HLA  HC/~zm) 
class I heavy chain/Bzm complexes.  Asterisk. (,) indicates HLA-B*0702 class I heavy chain dimers that are not dissociated  under nonreducing condi- 
tions. Monomeric HLA class I heavy  chains migrate as two discrete bands on nonreducing gels. Both monomeric B*0702 species exhibit identical 
peptide patterns after digestion with  V8 proteinase (Fig. 3). 
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tates using the latter antibodies has been observed consistently 
in numerous experiments,  but has  not been seen in mouse 
cells, for which antibodies against either the H-2 class I com- 
plex or 32m  precipitated  detectable  amounts  of the cross- 
linked product (17). We, therefore, conclude that 32m is ab- 
sent in the human  160-kD cross-linked complex or present 
in amounts  undetectable with  the  antibodies  used. 
Composition of the Cross-linked 160-kD Complex.  To ana- 
lyze its component polypeptide chains the 160-kD cross-linked 
band was eluted and reanalyzed on SDS-PAGE after reduc- 
tion of the cross-linker.  When cells were biosynthetically la- 
beled for relatively short periods of time (15 min to 2 h) be- 
fore solubilization  and cross-linking  only the heavy chains 
of class I  molecules were detected (not  shown).  However, 
with overnight labeling bands corresponding to two proteins 
of 84 and 94 kD apparent molecular mass were detected in 
addition  to the HLA-heavy chain  (45  kD)  (Fig.  2).  As ex- 
pected from the known specificities  of the precipitating anti- 
bodies, 3zm  was not  found in  the  cross-linked  complex. 
Treatment of the cross-linked species with EndoH, an en- 
zyme that removes immature N-linked high mannose oligosac- 
charides from proteins, increased the mobility of all the class 
I  heavy  chains  (Fig.  2).  During  glycoprotein  maturation 
EndoH sensitivity is lost due to carbohydrate modification 
completed by the  time  glycoproteins  arrive at  the  medial- 
Golgi (45).  Therefore,  EndoH sensitivity of the HLA class 
Figure  2.  Component  proteins 
of the 160-kD  cross-linked  species. 
10% reducing  SDS-PAGE  showing 
the component proteins of the 
160-kD cross-linked  complex  iso- 
lated from B7C1R cells. Cells 
were radiolabeled  for 20 h. Diges- 
tion  with EndoH is  indicated 
(+, -). 
I heavy chain in the cross-linked complex is characteristic of 
class I heavy chains found in the ER or c/s-Golgi.  Neither the 
mobility of the 84-kD nor the 94-kD protein was affected by 
EndoH treatment indicating these proteins have no N-linked 
carbohydrate  (Fig.  2). 
The failure to detect the cross-linked 160-kD species with 
32m-dependent antibodies and the sensitivity of class I heavy 
chains to EndoH treatment  support a scheme in which the 
84-  and  the  94-kD  proteins  associate  with  immature  class 
I heavy chains at a stage in their maturation before the binding 
of 32m  and  egress from  the ER. 
The Cross-linked Proteins with Apparent Molecular Masses of 
94 and 84 kD Correspond  to Calnem'n and lmmunoglobulin Binding 
Protein (BiP).  Calnexin has been shown by Ahluwalia et al. 
(19) and Hochstenbach et al.  (22) to associate  with human 
and mouse class I molecules. BiP, a member of the heat shock 
protein family (HSP70) and like calnexin localized to the lumen 
of the ER, was originally described independently as the im- 
munoglobulin  heavy  chain  binding  protein  (46)  and  the 
glucose-regulated protein,  grp 78 (47).  Its characteristics of 
binding to immature,  unfolded, or misfolded proteins sug- 
gested a function  as molecular chaperone  (48). 
To determine if the 84- and 94-kD proteins in the cross- 
linked species correspond to either calnexin or BiP, proteins 
precipitated  with  antibodies against  calnexin and BiP were 
compared with the 94- and 84-kD proteins isolated from the 
160-kD cross-linked  species precipitated  with anti-class I HLA 
antibodies.  Similar electrophoretic  mobility on SDS-PAGE 
indicated that the 94-kD protein corresponds to calnexin  and 
the 84-kD protein to BiP, hypotheses that were substantiated 
by peptide  mapping  (Fig.  3). 
Calnexin and BiP Form Individual Complexes with Class I 
Heavy Chains That Coexist within the Cell.  Antibodies against 
calnexin and BiP were used for precipitation from DSP-treated 
cell extracts and the immunoprecipitates  compared to those 
obtained with anti-class  I antibodies. Antibodies against cal- 
nexin and class I molecules gave cross-linked products of 160 
kD similar in size (Fig.  4 a) further confirming the presence 
of calnexin in the  160-kD band precipitated with anti-class 
I antibody.  The antibody against BiP, however, did not precipi- 
tate the cross-linked species (not shown), suggesting that the 
epitope recognized by the anti-grp78/BiP antibody has been 
lost or is inaccessible in  the cross-linked  complex. 
Reduction of the 160-kD bands obtained with either anti- 
calnexin  or  anti-class  I  antibodies  gave both  the  EndoH- 
sensitive class  I  heavy chain  band  and  the 94 kD/calnexin 
band. The BiP band was seen only in the 160-kD cross-linked 
species  immunoprecipitated  with  antibodies  against  class  I 
HLA molecules, but not in complexes isolated with the anti- 
calnexin  monoclonal antibody. This suggests that the 160-kD 
band detected with antibodies against class I HLA molecules 
represents two individual complexes consisting of either cal- 
nexin and class I heavy chains or BiP and class I heavy chains. 
Ternary complexes consisting ofcalnexin, BiP, and class I heavy 
chains  with  expected molecular mass greater  than  160 kD 
were not  detected in our  system. 
Dtfferences in the Cross-linked Species Formed by Human and 
Mouse Class I Heavy Chains.  Differences in the early matu- 
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V8 proteinase. Peptide patterns for the following proteins are shown: cal- 
nexin (lane I), the 94 kD (lane 2), and 84 kD (lane 3) proteins that are 
the component proteins of the 160-kD  complex precipitated with anti- 
body Q1/28, grp78/BiP (lane 4), and grp94 (lane 5). Two species of HLA- 
B*0702  heavy chains distinguished under nonreducing conditions were 
analyzed; the band showing slower electrophoretic mobility (lane 6) and 
the band with faster electrophoretic mobility (lane  7). Peptide patterns 
for both HLA class I heavy chain species are identical. Unrelated proteins 
(calnexin, BiP, grp94, HLA class I heavy chains) show distinctively different 
digestion patterns attesting to the validity of the assay in assessing protein 
relationships.  Enhanced  gels were exposed  for 5 wk. 
ration events of human and mouse class I heavy chains have 
been found. First, calnexin is found associated with free H-2 
heavy chains and with heavy chains bound to/sam in mouse 
(17). In contrast, in human cells calnexin (94 kD) is found 
associated only with free class I HLA heavy chains. Second, 
association of BiP with class I was found in human cells but 
not in mouse cells (17, 18, and Fig. 5 b, lanes 1-4). To inves- 
tigate further these differences we analyzed human C1K calls 
that had been transfected with the mouse class I heavy chain 
gene H-2K  b. In these cells, the H-2K  b heavy chain is forced 
to  assemble  with  human  /sam  and  interact  with  human 
chaperones. 
Immunoprecipitation with antibodies specific  either for con- 
formational epitopes of the H-2K  b molecule, for free H-2K  b 
heavy chains,  or for human/~am, all gave a cross-linked spe- 
cies of 160 kD (Fig. 5 a). Reduction of the complex revealed 
bands corresponding to H'2K b heavy chain and to calnexin, 
but not to BiP (Fig.  5 b). In the environment of the human 
cell, the H-2K  b heavy chains behave similarly to when they 
are in mouse cells in that they bind simultaneously to cal- 
nexin and/sam while showing no affinity for BiP (Fig. 5 b). 
This  experiment,  therefore,  suggests  that  the capacity of 
~/2m and calnexin to  associate  simultaneously with class I 
heavy chains and of BiP  to bind class I heavy chains are a 
function of differences in human and mouse class I heavy chain 
sequences and not of the species from which either/sam or 
the chaperones are derived. 
/s2rn Binding Can Induce Dissociation of Calnexin and BiP 
from the Class I Heat,? Chains.  The binding of calnexin and 
BiP to class I HLA heavy chains appears to take place before 
association with/Sam. Indeed,/s2m binding and association 
with calnexin and BiP seem to represent mutually exclusive 
interactions.  In the context of this hypothesis it was of in- 
terest to examine Daudi,  a human cell line devoid of/s2m 
in which HLA class I heavy chains are retained intracellu- 
larly (12). Cross-linking experiments showed presence of the 
160-kD cross-linked species and results from pulse/chase ex- 
periments suggested that in the absence of/s~m the interac- 
tions of class I heavy chains with either BiP or calnexin were 
stable  (18). 
331  Nrgner and  Parham 
Figure 4.  94 kD/calnexin and 84 kD/BiP are not found 
in the same cross-linked complex.  (a) 10%  nonreducing 
SDS-PAGE showing precipitation from long-term labeled 
BTC1R using antibody Q1/28 (lanes I and 2) specific for 
free class I heavy chains  and antibody AF8 (hnes 3 and 
4) recognizing calnexin. Cross-linking was performed as 
indicated (+/-). Arrows indicate the 160-kD cross-linked 
complexes and 94 kD/calnexin. HLA-class I heavy chain 
dimers are indicated by an asterisk (*). The precise nature 
of the 110 kD band (^) is unknown.  Upon reanalysis of 
the excised band only a band of 90 kD corresponding to 
calnexin was observed (not shown). Therefore, the 110-kD 
species might represent  calnexin  dimers or calnexin  as- 
sociated with other, yet unlabeled, proteins.  (b) 160-kD 
cross-linked comple~s were eluted from non-reducing gels 
(shown in a, lanes 2 and 4), reduced and component pro- 
teins separated on 12.5%  SDS-PAGE. (-) and (+) indi- 
cate whether EndoH digestion was performed. Lane 1, 
calnexin precipitated with the and-c.alnexin antibody AF8. 
Lanes 2 and 3, component proteins of the 160-kD cross- 
linked species precipitated  using anti-calnexin antibody; 
lanes 4 and 5: component proteins of the 160-kD com- 
plexes precipitated using antibody Q1/28. Figure 5.  Comparison of the chaperones associated with mouse and human class I MHC proteins. (a) 10% nonreducing SDS-PAGE. Human C1R 
cells transfected with either mouse H-2K  b (lanes I-6) or human HLA-B*0702 (lanes 8-11) and mouse cell EL4 (lane 7) were labeled for 15 min and 
lysed in the absence (-, lanes I-3)  or presence (+, lanes 4-11) of DSP. Exposure time was overnight,  except for lane 8 which was exposed for 6 h. 
Antibodies used for immunoprecipitation  .were: anti-human B2m antibody, L368 (lanes 2, 5, and 10); anti-H-2 K  b antibody, 20-8-4s (lanes 3, 6, and 
7); anti-human free class I HLA heavy chain antibody, Q1/28 (lane 8); anti-human heavy chain/B2m antibody, W6/32 (lane 9); nonimmune serum 
(lanes 1, 4, and 11). Class I heavy chains (HC), cross-linked class 1 heavy chain/~2m complexes (H-2 HC/B2m and HLA HC//~2m),  and 160-kD 
cross-linked complexes are indicated. Mouse and human cross-linked complexes have very similar electrophoretic mobilities in the gel systems employed 
thus they are both referred to as 160-kD complexes. H-2 class I heavy chains and their B2m complexes exhibit slower electrophoretic mobility than 
their human counterparts due to more extensive glycosylation. (b) 12.5% reducing SDS-PAGE showing component proteins of different 160-kD com- 
plexes. EndoH digestion was performed on half of each samples (+). 160-kD complexes were isolated from: mouse cell lines, MDAY.D2 (lanes I and 
2) and EL4 (lanes 3 and 4), human cell line C1R transfected with mouse class I allele H-2 K  b (lanes 5 and 6) or human class I allele HLA-B7 (lanes 
7 and 8) are shown.  Exposure time of enhanced gel was 1 wk. Mouse calnexin has a slightly faster electrophoretic  mobility than human calnexin. 
A band with slightly slower electruphoretic mobility than EndoH resistant K  b heavy chains (lanes 3-6) was not detected consistently in different ex- 
periments and most likely is some experimental artifact. 
To test the hypothesis that ~82m binding and chaperone 
association are mutually exclusive interactions, the effect of 
adding/J2na to Daudi cell extracts before cross-linking was 
examined./~2m added in this way was able to associate with 
class I heavy chains as shown by precipitation with antibodies 
specific for the heavy chain/B2m complex (W6/32;  Fig.  6 
a). The efficiency to form heterodimers varied among the four 
allelic products (Fig.  6 a) and overall,  it was only a portion 
of the class I heavy chains that was converted into heterodi- 
mers  even  after  addition  of the  highest  concentration of 
~2m.  The remaining free class I  heavy chains were detect- 
able by antibody Q1/28 (not shown). In cross-linked samples, 
addition  of exogenous ~2m  decreased the  amount  of the 
160-kD  species in a dose-dependent manner (Fig.  6,  b and 
c). The decrease in the amount of the 160-kD  species was 
paralleled by an increase in a 55-kD species consisting of heavy 
chains and 32m. This inverse relationship suggests that en- 
gagement of 32m with the heavy chains in vivo leads to dis- 
sociation of the 160-kD  class I/chaperone complexes. The 
reactivity of Q1/28 with heterodimers in this experiment that 
is not observed in situations where heterodimers form natu- 
rally, is possibly due to conformational differences between 
heterodimers forced to form in detergent lysates  from free 
heavy chains  and  exogenous  B2m  and  those  formed nat- 
urally. 
Assembly of Class I HLA Molecules Is Slower in CIR Tram- 
fectants than in Normal B-LCL.  We found that the amount 
of the 160-kD cross-linked species detected in Daudi cells and 
C1R cells transfected with HLA-B genes was considerably 
greater than  that in  normal B cell lines.  In Daudi,  this is 
probably due to lack of/32m expression. In contrast, C1R 
cells that express  normal level of 32m have a different de- 
fect. C1R was derived from a normal EBV cell line by suc- 
cessive rounds of mutagenesis and selection with anti-HLA- 
A,B,C antibodies: one HLA-A,B,C haplotype is ddeted; for 
the other haplotype HLA-A is not expressed,  HLA-B ex- 
pression is highly reduced due to a mutation in the initiation 
codon, and the expression of HLA-C is normal (34).  De- 
spite the mutations, transfection of exogenous class I genes 
into CIR yields levels of surface expression comparable to 
those  found  on  normal  EBV  transformed cell  lines  (not 
shown). It is possible,  however, that the mutation in C1R 
332  Interaction  of MHC Class I Molecules with Chaperones Figure 6.  ~2m  binding can 
induce  dissociation  of  the 160-kD 
complex  in Dandi cells. (a) Radio- 
labded Daudi calls were lysed  in 
the presence  of  exogenously  added 
human Bzm or chicken  egg lyso- 
zyme. HLA class I heterodimers 
were precipitated with antibody 
W6/32 and analyzed  by IEF. Po- 
fit-ions  for HLA-A*0102,  A,6601, 
B,5801, and B-5802 are indi- 
cated. (b) Quantitation  of  autora- 
diogra  m (shown  in c). The amount 
of total class I heavy  chains in 
each lane  was calculated  as: 45 kD 
HC plus 55 kD HC/B2m plus 
160 kD HC/protein complexes. 
Radioactivity present  in  the 
160-kD band (darh bars) or 55-kD 
band  (crosshatched  Mrs) is expressed 
as percentage of the calculated 
total HC of  the same  lane. (c) Ra- 
diolabeled  Daudi cells  were  lysed 
and cross-linked  in presence  of  in- 
creasing amounts of B2m. Pro- 
teins were precipitated using an- 
tibody Q1/28 and analyzed  on 
10%  nonreducing SDS-PAGE. 
For quantitation  of radioactivity, 
gels were  dried  without enhance- 
ment and exposed to  a Phos- 
phorlmage plate (Molecular  Dy- 
namics, Sunnyvale, CA). The 
amount of  radioactivity  in a pro- 
tein band was determined and a 
background  value,  obtained  from 
an area of the gel not containing 
a band, was subtracted. 
affects the assembly and maturation of class I molecules in 
a more subtle way that facilitates detection of the cross-linked 
160-kD  species. 
To investigate this possibility, the assembly of HLA-B*0702 
and B'2705 molecules in C1R transfectants and normal EBV 
transformed cell lines was compared. Significant differences 
were  observed  (Fig.  7).  The  rates  of formation of heavy 
chain/fl2m dimers and acquisition of EndoH resistance were 
more rapid in B cell lines than CIR transfectants.  The overall 
kinetics of  class I assembly and transport from the ER through 
Golgi to the plasma membrane were slower in the C1R trans- 
fectants, resulting in a larger pool of free class I heavy chains 
within the EtL. These flee heavy chains are probably associated 
with calnexin and BiP and it is their abundance that prob- 
ably facilitates  detection of the 160-kD  complexes. 
Discussion 
Our experiments identify  complexes formed between class 
I HLA heavy chains and either calnexin or BiP. These com- 
plexes have been isolated by immunoprecipitation from de- 
tergent lysates and analyzed by SDS-PAGE. Their detection 
requires chemical cross-linking simultaneous with detergent 
solubilization, suggesting that the complexes are dissociated 
by the immunoprecipitation procedure. 
The finding of an association  between calnexin and class 
I confirms the results obtained by the groups of Williams 
(17-19) and Brenner (22, 23). Our analyses, however, reveal 
differences in the calnexin association of human and mouse 
class I heavy chains.  First, calnexin association is only ob- 
served for free HLA class I heavy chains and not for heterodi- 
mers of class I heavy chains and B2m. Moreover, addition 
of exogenous fl2m induces dissociation of the cross-linked 
class I/protein complexes indicating that simultaneous associ- 
ation of HLA class I heavy chains with calnexin and/32m 
is not a stable  situation. 
A  second difference is that BiP is found associated  with 
human but not with mouse class I heavy chains.  These spe- 
cies-specific differences in chaperone association appear to be 
a function of amino acid differences in the protein sequences 
of HLA and H-2 heavy chains. Mouse H-2 heavy chains ex- 
pressed in human cells retain their mouse pattern of  behavior, 
in that they associate with calnexin either as flee heavy chains 
or associated  with Bzm but do not associate with BiP. 
A third difference we find is that complexes of class I heavy 
Figure  7.  Maturation of HLA-B7 
expressed in transfected  CIR cells and 
normal  B cell  line. CIR cells  transfected 
with B*0702 (top  panel)  and JY,  a 
normal EBV-infected  B cell line that is 
homozygons  for B*0702 (bottom_panel) 
were pulse-hbded  for 10 min and chased 
for the times indicated, For immuno- 
precipitation antibodies ME1, specific 
for  B2m-associated HLA-B7, and 
Q1/28, reactive with HLA-B7 heavy 
chains, were  used. Samples  were treated 
with EndoH as indicated (+). 
333  N68ner  and Parham chains with calnexin and BiP are more difficult to detect in 
"normal" human cell lines compared with normal mouse cells. 
Characterization of the human complexes has been facilitated 
by the use of two mutant cell lines in which the assembly 
of class I HLA molecules is impaired. In the Daudi cell line 
the  absence  of ~/2m prevents  assembly  and  egress  of the 
heavy chains from the ER;  in C1R cells the kinetics of as- 
sembly is slowed for reasons that are unknown. However, 
a common feature of the phenotype of Daudi and C1R cells 
is that class I HLA heavy chains remain in the ER for longer 
times than in normal cells,  a property that probably facili- 
tates detection of the complexes with calnexin and BiP. Sup- 
porting this view are the results of our studies on normal 
EBV-transformed B cell lines. The rate at which class I HLA 
heavy chains of different alleles are assembled and discharged 
from the ER varies (49, 50) and the 160-kD cross-linked com- 
plexes are more easily detected for allelic products that show 
slower assembly kinetics, B51 and B27 for example, than for 
those which assemble  more rapidly. 
From their studies of mouse class I molecules, Degen and 
Williams found that association of calnexin correlates with 
EndoH sensitivity and thus transport from the ER to the 
Golgi (17). In contrast we find that for human class I mole- 
cules the dissociation of  calnexin and BiP appears more strongly 
correlated with ~82m association than with the site of intra- 
cellular localization. 
Since its first definition as an immunoglobulin binding pro- 
tein (46),  BiP association has been described for other pro- 
teins and its function as a molecular chaperone established 
(48).  More recent studies (17, 51, 52) provide evidence that 
another ER protein, calnexin, might also function as a mo- 
lecular chaperone.  We and others found that calnexin and 
BiP bind to newly synthesized molecules including class I 
heavy chains. These chaperones may act positively by facil- 
itating correct folding and ~2m association of class I heavy 
chains or negatively by ensuring ER retention and intracel- 
lular degradation of misfolded class I heavy chains.  That BiP 
and calnexin bind independent sets of  class I HLA heavy chains 
suggests they have complementary roles in class I biogenesis, 
a hypothesis consistent with what is known of calnexin and 
BiP function in other systems: calnexin preferentially associates 
with immature, but not aggregated glycoproteins (24,  53), 
whereas BiP binds to incompletely folded polypeptides that 
may be aggregated (24). One possible scheme is that the com- 
plexes of class I HLA heavy chains with BiP and calnexin 
represent two distinct pathways of folding, for example cal- 
nexin association may mark the pathway leading to functional 
class I molecules, whereas BiP association may mark the path- 
way to intracellular degradation. An alternative sheme is that 
complexes with BiP and calnexin represent successive inter- 
mediates in the same pathway of class I HLA folding. In an 
attempt to distinguish the two schemes we performed pulse/ 
chase experiments. However, under pulse labeling conditions 
neither BiP nor calnexin incorporated detectable radioactivity 
although the 160-kD cross-linked band was detected on ac- 
count of  radioactivity incorporated into the class I HLA heavy 
chains. 
The order in which ~2m and peptide bind to class I heavy 
chains in vivo is uncertain. Most evidence favors an initial 
association with 32m (54) but experiments supporting the 
binding of peptide first have also been reported (55, 56). The 
issue is complicated by differences in species, alleles, in vitro 
systems and the possibility that both pathways may be opera- 
tive.  Of relevance to this debate is the finding of a physical 
association between class I HLA molecules and the TAP/pep- 
tide transporter which resulted in peptide loading (57). Only 
32m-associated  heavy chains  were  found  to  be  associated 
with the TAP proteins showing that association of heavy chains 
with ~2m precedes association with  peptide. 
These findings suggest a scheme for class I HLA biosyn- 
thesis (Fig.  8) in which newly synthesized heavy chains as- 
sociate with either calnexin or BiP. Both chaperone proteins 
may function similarly to retain class I heavy chains in a con- 
formation compatible for B2m binding. However, we favor 
a model in which calnexin and BiP have distinctive roles. Com- 
patible with the features described for BiP association in other 
systems (24, 48, 58, 59) it seems most likely that misfolded 
class I heavy chains will form complexes with BiP resulting 
in their retention and eventual destruction. In contrast, cal- 
nexin association may be targeted towards immature class I 
heavy chains  which  have conformations compatible  with 
~2m binding. Association with calnexin may help maintain 
such  conformations  until  association  with  B2m  occurs. 
Binding of ~2m will release calnexin and facilitate  associa- 
Figure  8.  Hypothetical  model for 
the events  controlling  HLA class I as- 
sembly in the ER. 
334  Interaction  of MHC Class I Molecules  with Chaperones tion  with  the  peptide  transporter  proteins.  After  peptide 
loading class I molecules are released from the ER for transit 
through  the Golgi to the cell surface.  In such a model the 
chaperone proteins,  BiP and calnexin,  and proteins for the 
peptide transporters provide "quality control" functions on 
the assembly of human  class  I MHC proteins. 
Association with/32m profoundly influences the confor- 
mation of class I MHC heavy chains.  This stems from the 
extensive interaction of Bzm with all three extracellular do- 
mains (or1, or2, and o~3) of the class I heavy chain  (60, 61). 
For some time it has been appreciated that  the association 
between class I heavy chains and ~2m in mice is weaker than 
in humans and in contrast  to the human  situation associa- 
tion  with/32m  is not  a  necessary requirement  for mouse 
class I heavy chains to reach the cell surface (26, 28). A similar 
lassitude  seems  to  extend  to  the  association  of putative 
chaperones with the class I heavy chains of the two species. 
Whereas calnexin  binds to both flee and flzm-associated  H-2 
heavy chains,  its interaction  in human  cells is restricted to 
free class I  heavy chains.  Further  adding  to the control of 
human class I MHC assembly is a second putative chaperone, 
BiP, not detected in the mouse system which is also specifically 
targeted to free class I heavy chains.  For class I MHC mole- 
cules,  association with/32m represents a critical point in the 
biosynthesis and assembly of functional antigen  presenting 
molecules.  The impression emerging from this analysis is that 
intracellular  HLA class I heavy chains are either associated 
with B2m or with one of two chaperone molecules, BiP and 
calnexin.  Association with BiP and calnexin appears to serve 
the dual purpose of ensuring that class I heavy chains cannot 
reach the cell surface in the absence of/32m and to facilitate 
that association. All in all, the controls upon class I assembly 
appear more stringent  in humans  than  in mice. 
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